Ionization, lipophilicity and solubility properties of repaglinideMANDIC, Zoran; GABELICA, Vesna.Journal of pharmaceutical and biomedical analysis. 2006, Vol 41, Num 3, pp 866-871, issn 0731-7085, 6 p.Article

Kir6.2-dependent high-affinity repaglinide binding to β-cell K_ATP channelsHANSEN, Ann Maria K; HANSEN, John Bondo; CARR, Richard D et al.British journal of pharmacology. 2005, Vol 144, Num 4, pp 551-557, issn 0007-1188, 7 p.Article

Effects of the SLCO1B1*1B haplotype on the pharmacokinetics and pharmacodynamics of repaglinide and nateglinideKALLIOKOSKI, Annikka; BACKMAN, Janne T; NEUVONEN, Pertti J et al.Pharmacogenetics and genomics (Print). 2008, Vol 18, Num 11, pp 937-942, issn 1744-6872, 6 p.Article

A Comparative Study of First-Derivative Spectrophotometry and Column High-Performance Liquid Chromatography Applied to the Determination of Repaglinide in Tablets and for Dissolution TestingALKHALIDI, Bashar A; SHTAIWI, Majed; ALKHATIB, Hatim S et al.Journal of AOAC International. 2008, Vol 91, Num 3, pp 530-535, issn 1060-3271, 6 p.Article

Population pharmacokinetic modelling of repaglinide in healthy volunteers by using Non-Parametric Adaptive Grid AlgorithmRUZILAWATI, A. B; MOHD SUHAIMI, A. W; GAN, S. H et al.Journal of clinical pharmacy and therapeutics (Print). 2010, Vol 35, Num 1, pp 105-112, issn 0269-4727, 8 p.Article

Repaglinide/bedtime NPH insulin is comparable to twice-daily NPH insulinPANELO, Araceli; WING, Jeffrey Robert.Diabetes care. 2005, Vol 28, Num 7, pp 1789-1790, issn 0149-5992, 2 p.Article

Meglitinide analogues : a review of clinical data focused on recent trialsBLICKLE, J. F.Diabetes & metabolism. 2006, Vol 32, Num 2, pp 113-120, issn 1262-3636, 8 p.Article

Rifampicin seems to act as both an inducer and an inhibitor of the metabolism of repaglinideBIDSTRUP, Tanja Busk; STILLING, Nicolaj; DAMKIER, Per et al.European journal of clinical pharmacology. 2004, Vol 60, Num 2, pp 109-114, issn 0031-6970, 6 p.Article

Polymorphic organic anion transporting polypeptide 1B1 is a major determinant of repaglinide pharmacokineticsNIEMI, Mikko; BACKMAN, Janne T; KAJOSAARI, Lauri I et al.Clinical pharmacology and therapeutics. 2005, Vol 77, Num 6, pp 468-478, issn 0009-9236, 11 p.Article

Alternative efficient tritium labeling of repaglinideVLIEGEN, Maarten; HASPESLAGH, Pieter; VERLUYTEN, Willy et al.Journal of labelled compounds & radiopharmaceuticals. 2012, Vol 55, Num 3-4, pp 155-157, issn 0362-4803, 3 p.Article

Development and validation of a new high-performance liquid chromatography method for the determination of gliclazide and repaglinide in pharmaceutical formulationsBERECKA, Anna; GUMIENICZEK, Anna; HOPKALA, Hanna et al.Journal of AOAC International. 2006, Vol 89, Num 2, pp 319-325, issn 1060-3271, 7 p.Article

In vitro characterization and in vivo toxicity study of repaglinide loaded poly (methyl methacrylate) nanoparticlesDHANA LEKSHMI, U. M; POOVI, G; KISHORE, Narra et al.International journal of pharmaceutics (Print). 2010, Vol 396, Num 1-2, pp 194-203, issn 0378-5173, 10 p.Article

Effects of SLCO1B1 polymorphisms on the pharmacokinetics and pharmacodynamics of repaglinide in healthy Chinese volunteersJIAKE HE; ZHIXIA QIU; JIANHENG ZHENG et al.European journal of clinical pharmacology. 2011, Vol 67, Num 7, pp 701-707, issn 0031-6970, 7 p.Article

The effect of SLCO1B1 polymorphism on repaglinide pharmacokinetics persists over a wide dose rangeKALLIOKOSKI, Annikka; NEUVONEN, Mikko; NEUVONEN, Pertti J et al.British journal of clinical pharmacology. 2008, Vol 66, Num 6, pp 818-825, issn 0306-5251, 8 p.Article

Lack of effect of acute repaglinide administration on postprandial lipaemia in patients with type 2 diabetes mellitusTENTOLOURIS, N; KOLIA, M; KATSILAMBROS, N et al.Experimental and clinical endocrinology & diabetes. 2003, Vol 111, Num 6, pp 370-373, issn 0947-7349, 4 p.Article

Effects of gemfibrozil, itraconazole, and their combination on the pharmacokinetics and pharmacodynamics of repaglinide: potentially hazardous interaction between gemfibrozil and repaglinideNIEMI, M; BACKMAN, J. T; NEUVONEN, M et al.Diabetologia (Berlin). 2003, Vol 46, Num 3, pp 347-351, issn 0012-186X, 5 p.Article

Achieving Glycosylated Hemoglobin Targets Using the Combination of Repaglinide and Metformin in Type 2 Diabetes : A Reanalysis of Earlier Data in Terms of Current TargetsMOSES, Robert G.Clinical therapeutics. 2008, Vol 30, Num 3, pp 552-554, issn 0149-2918, 3 p.Article

Method development and validation of repaglinide in human plasma by HPLC and its application in pharmacokinetic studiesABU BAKAR RUZILAWATI; MOHD SUHAIMI ABD. WAHAB; IMRAN, Ahmad et al.Journal of pharmaceutical and biomedical analysis. 2007, Vol 43, Num 5, pp 1831-1835, issn 0731-7085, 5 p.Article

Lack of effect of bezafibrate and fenofibrate on the pharmacokinetics and pharmacodynamics of repaglinideKAJOSAARI, Lauri I; BACKMAN, Janne T; NEUVONEN, Mikko et al.British journal of clinical pharmacology. 2004, Vol 58, Num 4, pp 390-396, issn 0306-5251, 7 p.Article

Transfer of repaglinide in the dually perfused human placenta and the role of organic anion transporting polypeptides (OATPs)TERTTI, Kristiina; PETSALO, Aleksanteri; NIEMI, Mikko et al.European journal of pharmaceutical sciences. 2011, Vol 44, Num 3, pp 181-186, issn 0928-0987, 6 p.Article

Severe Hypoglycemia from Clarithromycin-Repaglinide Drug InteractionKHAMAISI, Mogher; LEITERSDORF, Eran.Pharmacotherapy. 2008, Vol 28, Num 5, pp 682-684, issn 0277-0008, 3 p.Article

A novel calcium silicate based microspheres of repaglinide : In vivo investigationsJAIN, Sunil K; AGRAWAL, Govind P; JAIN, Narendra K et al.Journal of controlled release. 2006, Vol 113, Num 2, pp 111-116, issn 0168-3659, 6 p.Article

The impact of CYP2C8 polymorphism and grapefruit juice on the pharmacokinetics of repaglinideBIDSTRUP, Tanja Busk; DAMKIER, Per; OLSEN, Anette Kristensen et al.British journal of clinical pharmacology. 2006, Vol 61, Num 1, pp 49-57, issn 0306-5251, 9 p.Article

Effect of repaglinide, administered two or three times daily for 3 months, on glycaemic control in Japanese patients with type 2 diabetes mellitusKAMIYAMA, Hiroshi; AOKIL, Kazutaka; NAKAJIMA, Shigeru et al.Journal of international medical research. 2014, Vol 42, Num 5, pp 1246-1256, issn 0300-0605, 11 p.Article

Meal-induced platelet activation in Type 2 diabetes mellitus : effects of treatment with repaglinide and glibenclamideYNGEN, M; ÖSTENSON, C.-G; HJEMDAHL, P et al.Diabetic medicine. 2006, Vol 23, Num 2, pp 134-140, issn 0742-3071, 7 p.Article